[1] Newman E A,Abdessalam S,Aldrink J H,et al. Update on neuroblastoma[J]. J Pediatr Surg,2019,54(3):383
[2] Nakagawara A,Li Y,Izumi H,et al. Neuroblastoma[J]. Nat Rev Dis Primers,2016,2(3):16079
[3] Tomolonis J A,Agarwal S,Shohet J M. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development[J]. Cell Tissue Res,2018,372(2):245
[4] Kholodenko I V,Kalinovsky D V,Doronin I I,et al. Neuroblastoma origin and therapeutic targets for immunotherapy[J]. J Immunol Res,2018,2018:7394268
[5] Aygun N. Biological and genetic features of neuroblastoma and their clinical importance[J]. Curr Pediatr Rev,2018,14(2):73
[6] Teitz T,Inoue M,Valentine M B,et al. Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis[J]. Cancer Res,2013,73(13):4086
[7] Jiao X,Sherman B T,Huang D W,et al. DAVID-WS: a stateful web service to facilitate gene/protein list analysis[J]. Bioinformatics,2012,28(13):1805
[8] Hulsegge I,Kommadath A,Smits M A. Globaltest and GOEAST: two different approaches for gene ontology analysis[J]. BMC Proc,2009, 3 (Suppl 4):S10
[9] Ogata H,Goto S,Sato K,et al. KEGG: kyoto encyclopedia of genes and genomes[J]. Nucleic Acids Res,1999,27(1):29
[10] Doncheva N T,Morris J H,Gorodkin J,et al. Cytoscape string app: network analysis and visualization of proteomics data[J]. J Proteome Res,2019,18(2):623
[11] Mühlethaler-Mottet A,Liberman J,Ascen?觭?觔o K,et al. The CXCR4/CXCR7/ CXCL12 axis is involved in a secondary but complex control of neuroblastoma metastatic cell homing[J]. PLoS One,2015, 10(5):e0125616
[12] Meier R,Mühlethaler-Mottet A,Flahaut M,et al. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth,but not invasion[J]. PLoS One,2007,2(10):e1016
[13] Tolbert V P,Matthay K K. Neuroblastoma: clinical and biological approach to risk stratification and treatment[J]. Cell Tissue Res,2018,372(2):195
[14] Ubellacker J M,Baryawno N,Severe N,et al. Modulating bone marrow hematopoietic lineage potential to prevent bone metastasis in breast cancer[J]. Cancer Res,2018,78(18):5300
[15] Balkwill F. Cancer and the chemokine network[J].Nat Rev Cancer,2004,4(7):540
[16] Zhang L,Yeger H,Das B,et al. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma[J]. Neoplasia,2007,9(1):36
[17] Klein S,Abraham M,Bulvik B,et al. CXCR4 promotes neuroblastoma growth and therapeutic resistance through miR-15a/16-1-Mediated ERK and BCL2/cyclin D1 pathways[J]. Cancer Res,2018,
78(6):1471
[18] Gross N,Meier R. Chemokines in neuroectodermal cancers: the crucial growth signal from the soil[J]. Semin Cancer Biol,2009,19(2):103
[19] Ulrich H,Ratajczak M Z,Schneider G,et al. Kinin and purine signaling contributes to neuroblastoma metastasis[J]. Front Pharmacol,2018,9:500
[20] Ma M,Ye J Y,Deng R,et al. Mesenchymal stromal cells May enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling[J]. Cancer Lett,2011,312(1):1
[21] Raffaghello L,Cocco C,Corrias M V,et al. Chemokines in neuroectodermal tumour progression and metastasis[J]. Semin Cancer Biol,2009,19(2):97
[22] Sanz-Rodríguez F,Hidalgo A,Teixidó J. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1[J]. Blood,2001,97(2):346
[1]庞学明,侯爱林,王笑一,等.小儿神经母细胞瘤的MRI诊断[J].天津医科大学学报,2014,20(02):154.
[2]聂红艳,邱艳丽,靳 燕,等.TIAM1蛋白在神经母细胞瘤中的表达及临床意义[J].天津医科大学学报,2019,25(02):143.
NIE Hong-yan,QIU Yan-li,JIN Yan,et al.Expression and Clinical Significance of TIAM1 in Neuroblastoma[J].Journal of Tianjin Medical University,2019,25(03):143.
[3]高伟靖,李龙.利用焦亡相关基因的特征预测神经母细胞瘤免疫微环境及其预后价值[J].天津医科大学学报,2023,29(04):379.
GAO Wei-jing,LI Long.Pyroptosis-related gene signature predicts the tumor microenvironment and prognosis in neuroblastoma[J].Journal of Tianjin Medical University,2023,29(03):379.